Adjuvant Therapy for Rectal Cancer
Clinics in Colon and Rectal Surgery · 01.01.2002 · 15 (01) · 055-062
DOI: 10.1055/s-2002-23568 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinics in Colon and Rectal Surgery, erschienen am 01.01.2002. Verfasst von Clifford Y. Ko und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
In 1990, the National Institutes of Health consensus statement for the treatment of rectal cancer concluded that ``combined postoperative chemotherapy and radiation therapy improves local control and survival in stage II and III patients and is recommended.'' Following the publication of this consensus statement, the conventional treatment for rectal cancer was bowel resection followed by adjuvant radiation and chemotherapy. In the years that followed, however, several new findings have been published and a multitude of issues has arisen. This article will attempt to succinctly focus on the best current evidence in the literature. Where possible, we include only Level I evidence (i.e., evidence from randomized controlled trials [RCTs]). Since the role of adjuvant therapy for rectal cancer is continuing to be modified, the purpose of this article is to describe and interpret the most current literature.
Zitieren
APA
Ko, C. Y., Stamos, M. J., Zimmerman, A., & Yang, H. C. (2002). Adjuvant Therapy for Rectal Cancer. Clinics in Colon and Rectal Surgery, 15(01), 055-062. https://doi.org/10.1055/s-2002-23568
Vancouver
Ko CY, Stamos MJ, Zimmerman A, Yang HC. Adjuvant Therapy for Rectal Cancer. Clinics in Colon and Rectal Surgery. 2002;15(01):055-062. doi:10.1055/s-2002-23568
BibTeX
@article{Ko2002,
author = {Ko, Clifford Y. and Stamos, Michael J. and Zimmerman, Arthur and Yang, Henry C.},
title = {Adjuvant Therapy for Rectal Cancer},
journal = {Clinics in Colon and Rectal Surgery},
year = {2002},
volume = {15},
number = {01},
pages = {055--062},
doi = {10.1055/s-2002-23568}
}
EUVIMED